Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks twiist insulin pump safety in thousands with type 1 diabetes

NCT ID NCT07356089

First seen Jan 21, 2026 · Last updated May 23, 2026 · Updated 14 times

Summary

This study is monitoring the safety and performance of the Twiist insulin delivery system in 1,875 adults and children (ages 6 and up) with type 1 diabetes. Participants are already using the Twiist system, and researchers will track severe low blood sugar events, diabetic ketoacidosis, and device-related problems. The goal is to gather real-world information to ensure the device works safely in everyday life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Jaeb Center for Health Research

    RECRUITING

    Tampa, Florida, 33647, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.